Salix Pharmaceuticals To Present At Three Investment Conferences In June

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at three investment conferences during June 2012. Information regarding these conferences is provided below:
Jefferies 2012 Global Healthcare Conference  
            New York, NY   Monday, June 4 3:30 p.m. ET
 
Goldman Sachs Global Healthcare Conference 2012
Long Beach, CA Wednesday, June 6 5:00 p.m. ET
 
Wells Fargo Securities Health Care Conference
Boston, MA Tuesday, June 19 1:30 p.m. ET

Interested parties can access a live audio web cast of the presentation at http://www.salix.com. A replay of the presentation will be available at the same location.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix’s strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company’s gastroenterology specialty sales and marketing team.

If you liked this article you might like

After Clearing Valeant Litigation, Jaguar and Napo Pharmaceuticals Reunite

Biotech Hits an Inflection Point

Put Agenus, Progenics on Your Small-Cap List

Put Agenus, Progenics on Your Small-Cap List

Put Agenus, Progenics on Your Small-Cap List

Put Agenus, Progenics on Your Small-Cap List

2 Small Biopharma Stocks on the Move

2 Small Biopharma Stocks on the Move